SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Hansson Göran)
 

Sökning: WFRF:(Hansson Göran) > Human papillomaviru...

  • Naucler, PontusLund University,Lunds universitet,Klinisk mikrobiologi, Malmö,Forskargrupper vid Lunds universitet,Clinical Microbiology, Malmö,Lund University Research Groups (författare)

Human papillomavirus and Papanicolaou tests to screen for cervical cancer.

  • Artikel/kapitelEngelska2007

Förlag, utgivningsår, omfång ...

  • Boston, Massachusetts :Massachusetts medical society,2007

Nummerbeteckningar

  • LIBRIS-ID:oai:lup.lub.lu.se:ab62fec5-4647-4e40-9c36-2775254be19e
  • https://lup.lub.lu.se/record/608508URI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-20694URI
  • https://doi.org/10.1056/NEJMoa073204DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:115974015URI
  • https://gup.ub.gu.se/publication/58590URI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-143335URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:art swepub-publicationtype
  • Ämneskategori:ref swepub-contenttype

Anmärkningar

  • Background Screening for cervical cancer based on testing for human papillomavirus (HPV) increases the sensitivity of detection of high-grade (grade 2 or 3) cervical intraepithelial neoplasia, but whether this gain represents overdiagnosis or protection against future high-grade cervical epithelial neoplasia or cervical cancer is unknown. Methods In a population-based screening program in Sweden, 12,527 women 32 to 38 years of age were randomly assigned at a 1:1 ratio to have an HPV test plus a Papanicolaou (Pap) test (intervention group) or a Pap test alone (control group). Women with a positive HPV test and a normal Pap test result were offered a second HPV test at least 1 year later, and those who were found to be persistently infected with the same high-risk type of HPV were then offered colposcopy with cervical biopsy. A similar number of double-blinded Pap smears and colposcopies with biopsy were performed in randomly selected women in the control group. Comprehensive registry data were used to follow the women for a mean of 4.1 years. The relative rates of grade 2 or 3 cervical intraepithelial neoplasia or cancer detected at enrollment and at subsequent screening examinations were calculated. Results At enrollment, the proportion of women in the intervention group who were found to have lesions of grade 2 or 3 cervical intraepithelial neoplasia or cancer was 51% greater (95% confidence interval [CI], 13 to 102) than the proportion of women in the control group who were found to have such lesions. At subsequent screening examinations, the proportion of women in the intervention group who were found to have grade 2 or 3 lesions or cancer was 42% less (95% CI, 4 to 64) and the proportion with grade 3 lesions or cancer was 47% less (95% CI, 2 to 71) than the proportions of control women who were found to have such lesions. Women with persistent HPV infection remained at high risk for grade 2 or 3 lesions or cancer after referral for colposcopy. Conclusions The addition of an HPV test to the Pap test to screen women in their mid-30s for cervical cancer reduces the incidence of grade 2 or 3 cervical intraepithelial neoplasia or cancer detected by subsequent screening examinations.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Ryd, WalterGothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för patologi,Institute of Biomedicine, Department of Pathology (författare)
  • Tornberg, SvenKarolinska Institutet (författare)
  • Strand, AndersUppsala universitet,Dermatologi och venereologi(Swepub:uu)andestra (författare)
  • Wadell, GöranUmeå universitet,Virologi(Swepub:umu)gowa0001 (författare)
  • Elfgren, Kristina (författare)
  • Radberg, ThomasGothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper,Institute of Clinical Sciences (författare)
  • Strander, Björn,1952Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper,Institute of Clinical Sciences(Swepub:gu)xstrbj (författare)
  • Forslund, OlaLund University,Lunds universitet,Klinisk mikrobiologi, Malmö,Forskargrupper vid Lunds universitet,Clinical Microbiology, Malmö,Lund University Research Groups(Swepub:lu)mikr-ofo (författare)
  • Hansson, Bengt-GöranLund University,Lunds universitet,Klinisk mikrobiologi, Malmö,Forskargrupper vid Lunds universitet,Clinical Microbiology, Malmö,Lund University Research Groups(Swepub:lu)mikr-bha (författare)
  • Rylander, EvaKarolinska Institutet (författare)
  • Dillner, JoakimKarolinska Institutet,Lund University,Lunds universitet,Klinisk mikrobiologi, Malmö,Forskargrupper vid Lunds universitet,Clinical Microbiology, Malmö,Lund University Research Groups(Swepub:lu)mikr-jdi (författare)
  • Johansson, Bo (författare)
  • Klinisk mikrobiologi, MalmöForskargrupper vid Lunds universitet (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:New England Journal of MedicineBoston, Massachusetts : Massachusetts medical society357:16, s. 1589-970028-47931533-4406
  • Ingår i:N Engl J MedBoston, Massachusetts : Massachusetts medical society357:16, s. 1589-97

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy